Lately, Wall Street economic commentary has been replete with ominous warnings. President Donald Trump’s tariffs are bound to cause an economic downturn, or perhaps even a recession.

The Wall Street Journal’s conservative editorial board continued with its needling of Donald Trump on Wednesday, this time explaining in a scathing article why it believes the president’s planned expansion of drug price controls should be a no-go.

U.S. and China to pause most tariffs for 90 days, slash reciprocal rates. Amazon-backed Scale AI sets sights on Saudi expansion. Trump vows to cut drug prices in the U.S. by up to 80%.